Expression of Epidermal Growth Factor Receptor Related Proteinin Gallbladder Cancer: An Association with p53 Mutation
Expression of Epidermal Growth Factor Receptor Related Protein in Gallbladder Cancer: An Association with p53 Mutation
1
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Background : It has been well demonstrated that the overexpression of epidermal growth factor receptor (EGFR) is associated with numerous gastrointestinal malignancies, including gallbladder carcinoma. However, the cellular events that regulate EGFR in cancer cells have not been fully elucidated. A novel negative regulator of EGFR that is referred to as EGFR related protein (ERRP) has recently been identified. The aim of this study was to investigate the expression and localization of ERRP in gallbladder carcinoma and to examine a possible role for ERRP. Methods : We examined the immunohistochemical expressions of ERRP, p53 and proliferating cell nuclear antigen labeling index (PCNA-LI) in formalin-fixed, paraffinembedded specimens of 43 cases of gallbladder carcinoma, 7 cases of adenoma and 3 cases of dysplasia. Results : In the normal mucosa, ERRP immunoreactivity was positive in over 64% of specimens. In contrast, the ERRP staining was positive in only 46% of the cancer specimens. The expression of ERRP in cancer cells was inversely correlated with tumor cell proliferation. The loss of ERRP expression correlated with the p53 overexpression. Conclusions : Our data indicate that the down-regulation or loss of ERRP could play an important role in the progression of gallbladder carcinoma. The inverse relationship between the ERRP expression and PCNA-LI suggests that ERRP may play a role in the inhibition of tumor cell proliferation in gallbladder cancer.
참고문헌 (21)
- "The type I(EGFR-related)family of growth factor receptors and their ligands", 4, pp.1~24 (1992)
- "Epidermal growth factor-related peptides and their relevance togastrointestinal pathophysiology", 108, pp.564~80 (1995)
- "Epidermal growth factor receptor immunoreactivity in gallbladder and extrahepatic biliary tract tumours", 191, pp.1087~91 (1995)
- "Cloning of a novel EGFR-related peptide:a putative negative regulator of EGFR", 280, pp.1083~9 (2001)
- "Differentiation-dependent expression of EGFR related protein(ERRP)in Caco-2 cells and colonic and pancreatic cancers", 122 (2002)
- "Epidermal growth factor receptor-related protein:a potential therapeutic agent for colorectal cancer", 124, pp.1337~47 (2003)
- "Reduced expression of epidermal growth factor receptor related protein in gastric cancer", 54, pp.201~6 (2005)
- "Expression of ERRP in normal and neoplastic pancreas and its relationship to clinicopathological parameters in pancreatic adenocarcinoma", 25, pp.342~9 (2002)
- "p53:the ultimate tumor suppressor gene", 6, pp.3169~76 (1992)
- "Wild-type p53 can downmodulate the activity of various promoters", 88, pp.9979~83 (1991)
- "A comparison of the biological activities of wild-type and mutant p53", 7, pp.855~65 (1993)
- "Pathology and genetics of tumours ofthe digestive system", IARC Press
- "Reduced expression of epidermal growth factor receptor-related protein in hepatocellular carcinoma:implications for cancer growth", 69, pp.219~24 (2004)
- "A truncated,secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue", 10, pp.2973~82 (1990)
- "Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells", 309, pp.418~25 (1984)
- "Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum", 68, pp.782~7 (1996)
- "inhibition of tyrosine kinase activity of the epidermal growth factor receptor by a truncated receptor form that binds to EGF role for interreceptor interaction in kinase regulation", 9, pp.671~7 (1999)
- "An immunohistochemical study of p53protein in gallbladder and extrahepatic bile duct", ampullary carcinomas, 1994, pp.74, 1542~5
- "Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours", 379, pp.88~91 (1996)
- "Expression of p53 protein in gastric cancer:an immunohistochemical study with correlation to proliferative activity", 17, pp.513~7 (1997)
- "DNA flow cytometry,p53 levels and proliferative cell nuclear antigen in human colon dysplastic,precancerous and cancerous tissues", 18, pp.1677~82 (1998)